| 1 |
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al. · The Lancet
Open access |
24 Jan 2020 |
52,028 |
| 2 |
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al. · The Lancet
Open access |
30 Jan 2020 |
12,621 |
| 3 |
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender, Shai Fuchs, Ron Milo · PLoS Biology
Open access |
19 Aug 2016 |
5,258 |
| 4 |
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation
Open access |
27 Mar 2020 |
5,083 |
| 5 |
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin, Luo‐Qi Zhou, Ziwei Hu et al. · Clinical Infectious Diseases
Open access |
6 Mar 2020 |
5,047 |
| 6 |
Tolerance, Danger, and the Extended Family
Polly Matzinger · Annual Review of Immunology
|
Apr 1994 |
4,825 |
| 7 |
Unravelling the pathogenesis of inflammatory bowel disease
Ramnik J. Xavier, Daniel K. Podolsky · Nature
|
Jul 2007 |
4,394 |
| 8 |
Interactions Between the Microbiota and the Immune System
Lora V. Hooper, Dan R. Littman, Andrew J. Macpherson · Science
Open access |
6 Jun 2012 |
4,273 |
| 9 |
The Danger Model: A Renewed Sense of Self
Polly Matzinger · Science
|
12 Apr 2002 |
4,209 |
| 10 |
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
John Concato, Nirav R. Shah, Ralph I. Horwitz · New England Journal of Medicine
Open access |
22 Jun 2000 |
3,575 |
| 11 |
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Jamie Lopez Bernal, Nick J Andrews, Charlotte Gower et al. · New England Journal of Medicine
Open access |
21 Jul 2021 |
3,090 |
| 12 |
Trained immunity: A program of innate immune memory in health and disease
Mihai Gheorghe Netea, Leo A. B. Joosten, Eicke Latz et al. · Science
Open access |
21 Apr 2016 |
2,825 |
| 13 |
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan, Noam Barda, Eldad Kepten et al. · New England Journal of Medicine
Open access |
24 Feb 2021 |
2,818 |
| 14 |
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen J. Sawcer et al. · Nature
Open access241 authors |
Aug 2011 |
2,772 |
| 15 |
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
HCA Lung Biological Network, Waradon Sungnak, Ni Huang et al. · Nature Medicine
Open access |
23 Apr 2020 |
2,743 |
| 16 |
Defining trained immunity and its role in health and disease
Mihai Gheorghe Netea, Jorge Domínguez‐Andrés, Luis Bruno Barreiro et al. · Nature reviews. Immunology
ReviewOpen access |
4 Mar 2020 |
2,707 |
| 17 |
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton, Rachel King, Lindsay Rechtman et al. · Multiple Sclerosis Journal
Open access |
11 Nov 2020 |
2,668 |
| 18 |
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Ruslan M. Medzhitov, Charles A. Janeway · Cell
Open access |
Oct 1997 |
2,448 |
| 19 |
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Massimo Locati, Graziella Curtale, Alberto Mantovani · Annual Review of Pathology Mechanisms of Disease
ReviewOpen access |
17 Sep 2019 |
2,266 |
| 20 |
mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Shih‐Chin Cheng et al. · Science
Open access |
25 Sep 2014 |
2,266 |
| 21 |
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
Carlos Augusto Gomes · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Open access |
24 Mar 2020 |
2,230 |
| 22 |
Control of adaptive immunity by the innate immune system
Akiko Iwasaki, Ruslan M. Medzhitov · Nature Immunology
Open access |
19 Mar 2015 |
2,182 |
| 23 |
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Rein M G J Houben, Peter J. Dodd · PLoS Medicine
Open access |
25 Oct 2016 |
2,133 |
| 24 |
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Paola Italiani, Diana Boraschi · Frontiers in Immunology
Open access |
17 Oct 2014 |
2,104 |
| 25 |
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Christopher Troeger et al. · The Lancet Infectious Diseases
Open access144 authors |
19 Sep 2018 |
2,095 |
| 26 |
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Uğur Şahin et al. · Nature
Open access |
30 Sep 2020 |
2,072 |
| 27 |
Efficacy of BCG Vaccine in the Prevention of Tuberculosis
Graham A. Colditz · JAMA
|
2 Mar 1994 |
1,936 |
| 28 |
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
Einav G. Levin, Yaniv Lustig, Carmit Cohen et al. · New England Journal of Medicine
Open access |
6 Oct 2021 |
1,832 |
| 29 |
Evolution of the immune system in humans from infancy to old age
Anna Katharina Simon, Georg A. Holländer, Andrew James McMichael · Proceedings of the Royal Society B Biological Sciences
Open access |
22 Dec 2015 |
1,826 |
| 30 |
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
Sadia Saeed et al. · Science
Open access |
25 Sep 2014 |
1,805 |
| 31 |
Immunological Memory and Protective Immunity: Understanding Their Relation
Rafi Ahmed, David C. Gray · Science
|
5 Apr 1996 |
1,789 |
| 32 |
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Johanneke Kleinnijenhuis, Jessica Quintin, Frank W. M. B. Preijers et al. · Proceedings of the National Academy of Sciences
Open access |
17 Sep 2012 |
1,784 |
| 33 |
Gut microbiota dysbiosis contributes to the development of hypertension
Jing Li, Fangqing Zhao, Yidan Wang et al. · Microbiome
Open access |
31 Jan 2017 |
1,777 |
| 34 |
Immunity and Inflammation in Atherosclerosis
Dennis Wolf, Klaus Ley · Circulation Research
Open access |
17 Jan 2019 |
1,768 |
| 35 |
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J. Haas, Frederick J. Angulo, John M. McLaughlin et al. · The Lancet
Open access |
May 2021 |
1,764 |
| 36 |
Immunometabolism governs dendritic cell and macrophage function
Luke A.J. O'Neill, Edward J. Pearce · The Journal of Experimental Medicine
Open access |
22 Dec 2015 |
1,736 |
| 37 |
Trained Immunity: A Memory for Innate Host Defense
Mihai G. Netea, Jessica Quintin, Jos W. M. van der Meer · Cell Host & Microbe
Open access |
May 2011 |
1,711 |
| 38 |
A guide to vaccinology: from basic principles to new developments
Andrew John Pollard, Else Margreet Bijker · Nature reviews. Immunology
ReviewOpen access |
22 Dec 2020 |
1,621 |
| 39 |
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Andrew J. Macpherson, Therese Uhr · Science
|
11 Mar 2004 |
1,592 |
| 40 |
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J. Thomas et al. · New England Journal of Medicine
Open access |
15 Sep 2021 |
1,574 |
| 41 |
Innate immunity: impact on the adaptive immune response
Ruslan M. Medzhitov, Charles A. Janeway · Current Opinion in Immunology
ReviewOpen access |
Feb 1997 |
1,559 |
| 42 |
New use of BCG for recombinant vaccines
C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al. · Nature
|
6 Jun 1991 |
1,513 |
| 43 |
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Tao Zhang, Qunfu Wu, Zhigang Zhang · Current Biology
Open access |
19 Mar 2020 |
1,503 |
| 44 |
Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians
Elena Biagi, Lotta Nylund, Marco Candela et al. · PLoS ONE
Open access |
17 May 2010 |
1,503 |
| 45 |
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan · Nature Reviews Drug Discovery
ReviewOpen access |
6 Apr 2021 |
1,422 |
| 46 |
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N Ramasamy et al. · The Lancet
Open access421 authors |
19 Nov 2020 |
1,415 |
| 47 |
Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes, Delphine Boche, David G. Wilkinson et al. · The Lancet
|
Jul 2008 |
1,406 |
| 48 |
InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation
Karin Breuer, Amir B. K. Foroushani, Matthew R. Laird et al. · Nucleic Acids Research
Open access |
23 Nov 2012 |
1,399 |
| 49 |
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Jamie Lopez Bernal, Nick J Andrews, Charlotte Gower et al. · BMJ
Open access |
13 May 2021 |
1,398 |
| 50 |
Variation in protection by BCG: implications of and for heterologous immunity
Paul Fine · The Lancet
|
Nov 1995 |
1,395 |